Celiac Disease Treatment Market - Forecasts from 2018 to 2023
The global celiac disease treatment market is anticipated to witness a CAGR of 23.41% during the forecast period to reach a total market size of US$661.32 million by 2023, increasing from US$187.16 million in 2017. Celiac disease is a digestive disorder that makes it difficult for the body to absorb nutrients like fat, calcium, iron, and folate. It is an autoimmune disease in which lining of the small intestine is damaged when foods with gluten are eaten. This disease is genetic in nature and is common among people suffering from type 1 diabetes, Down syndrome, autoimmune thyroid disease, microscopic colitis, Addison’s disease and rheumatoid arthritis. The market for celiac disease treatment is expected to witness significant growth in the years ahead, driven by various anti-inflammatory drugs and therapeutic vaccines in the pipeline that are to replace or supplement a gluten-free diet. Rising healthcare expenditure, growing medical research, greater awareness about the disease is expected to further bolster this growth. Geographically, Europe and North America are the largest treatment markets for Celiac disease, owing to the high prevalence and a well-established healthcare landscape. Africa, on the other hand, is a market with great potential, given the fact that highest prevalence of the disease is found in the Saharawi people of Africa.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the SWOT Analysis. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the pressure sensors value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Innovative Biopharmaceuticals, Calypso Biotech, Cour Pharmaceuticals, Doctor Falk Pharmaceuticals, and Glenmark Pharmaceuticals Ltd. among others.
The celiac disease treatment market has been analyzed through following segments:
Vitamins and Dietary Supplements
Steroids and Immunosuppressive Drugs
Middle East and Africa